Heuler Scott 4
4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Mar 1, 2019
Insider Transaction Report
Form 4
Heuler Scott
Vice President of Sales
Transactions
- Award
Option to Purchase Common Stock
2019-01-01+100,365→ 100,365 totalExercise: $2.20Exp: 2029-01-01→ Common Stock (100,365 underlying)
Footnotes (2)
- [F1]On February 27, 2019, the Board of Directors of the Issuer determined that the fair market value of the Company's common stock as of January 1, 2019 was $2.20 per share.
- [F2]25% of the options were immediately exercisable, and the remaining options will vest in 36 equal monthly installments beginning on January 1, 2020.